Role of splicing factor SRSF1 in T cell function and autoimmunity
剪接因子 SRSF1 在 T 细胞功能和自身免疫中的作用
基本信息
- 批准号:9761988
- 负责人:
- 金额:$ 45.56万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-09-01 至 2021-08-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAlternative SplicingAmericanAntibodiesArginineArthritisAutoantibodiesAutoimmune DiseasesAutoimmunityB-LymphocytesBrainCD3 AntigensCD8B1 geneCRISPR/Cas technologyCell physiologyCellsCellular ImmunologyDataDefectDepositionDevelopmentDiseaseDisease modelDistalEnterobacteria phage P1 Cre recombinaseEstrogensExhibitsExperimental Autoimmune EncephalomyelitisFemale of child bearing ageFunctional disorderFundingGene ExpressionGene SilencingGenerationsGenesGoalsHistopathologyHomeostasisHormonalHumanImmuneImmune System DiseasesImmune ToleranceImmune systemImmunosuppressionIn VitroInfectionInfiltrationInflammatoryInterleukin-17Interleukin-2JointsKidneyKidney DiseasesKnockout MiceLengthLinkLoxP-flanked alleleLupusLupus NephritisLymphopeniaMass Spectrum AnalysisMature T-LymphocyteMediatingMemoryMentored Research Scientist Development AwardMessenger RNAMolecularMolecular ImmunologyMolecular TargetMusNamesNational Institute of Arthritis and Musculoskeletal and Skin DiseasesOligonucleotidesOrganPainPathogenesisPathologyPatientsPhenotypeProductionProtein AnalysisProtein IsoformsProteinsProteinuriaPublishingRNA SplicingReceptor SignalingRegulationResearch PersonnelRoleSerineSerumSignal TransductionSignaling MoleculeSkinSteroidsSystemSystemic Lupus ErythematosusT-Cell ReceptorT-LymphocyteT-Lymphocyte SubsetsTestingTherapeuticTissuesTranscriptWhole OrganismWomanagedbasechild bearingchronic autoimmune diseasecytokineexperimental studyimmune functionimmunopathologyimprovedlupus prone micemortalitynoveloverexpressionpromoterprotein expressiontargeted biomarkertherapeutic target
项目摘要
Systemic lupus erythematosus (SLE) is an autoimmune disease of unknown cause, which mainly afflicts
women in their childbearing years and affects multiple organs including the skin and joints with complications in
vital organs such as kidneys and brain. T cell dysfunction due to altered intracellular signaling, gene
expression, and function, is thought to be central in the pathogenesis of this disease. The applicant used a
discovery approach and identified a protein namely serine arginine-rich splicing factor 1 (SRSF1) as a
regulator of a critical signaling gene - CD3 zeta chain, in human T cells. Furthermore, the applicant showed
that SRSF1 is a novel regulator of interleukin (IL)-2, a cytokine necessary for T cell function. Interestingly, T
cells from several patients with SLE have reduced levels of SRSF1 and its overexpression improves IL-2
production. This suggests that aberrant SRSF1 expression may contribute to defective T cell function and
therefore to disease pathophysiology. To advance these concepts, and to determine the role of SRSF1 in the
immune system within a whole organism, the applicant has generated mice lacking the Srsf1 gene
conditionally in T cells. Intriguingly, this mouse has defects in T cell phenotype and function, including reduced
expression of CD3 zeta chain, reduced IL-2, and increased proinflammatory IL-17 cytokine production. The
mouse develops autoantibodies and signs of kidney disease. Interestingly, estrogen downregulates SRSF1
expression levels in T cells from healthy women but not men. Based on the preliminary evidence generated in
human T cells and in the T cell Srsf1-deficient mouse, the hypothesis is that SRSF1 is a critical regulator of T
cell function and its deficiency promotes the expression of autoimmunity and related pathology. To test this
hypothesis the applicant will - 1) Determine how SRSF1 controls T cell homeostasis and function and enables
development of autoimmunity and related pathology 2) Determine how T cell-specific deletion of SRSF1
influences spontaneous and induced autoimmune disease and 3) Determine the role and regulation of SRSF1
in T cells from SLE patients and normal subjects. The applicant proposes the characterization of a novel
mouse, which will help define the role of SRSF1 in T cell function and the expression of autoimmunity and
related pathology using cellular and molecular immunology approaches. In parallel, studies proposed in human
T cells will provide a molecular link to hormonal aspects of SLE pathogenesis. This proposal is well within the
scope and goals of the applicant's currently funded NIAMS K01 award, which is to develop to an independent
investigator.
系统性红斑狼疮(SLE)是一种病因不明的自身免疫性疾病
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Vaishali Moulton其他文献
Vaishali Moulton的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Vaishali Moulton', 18)}}的其他基金
Role of splicing factor SRSF1 in T cell function and autoimmunity
剪接因子 SRSF1 在 T 细胞功能和自身免疫中的作用
- 批准号:
9320987 - 财政年份:2016
- 资助金额:
$ 45.56万 - 项目类别:
Role and regulation of the splicing factor ASF/SF2 in human T lymphocyte physiolo
剪接因子ASF/SF2在人T淋巴细胞生理中的作用及调控
- 批准号:
8240884 - 财政年份:2012
- 资助金额:
$ 45.56万 - 项目类别:
Role and regulation of the splicing factor ASF/SF2 in human T lymphocyte physiolo
剪接因子ASF/SF2在人T淋巴细胞生理中的作用及调控
- 批准号:
8662203 - 财政年份:2012
- 资助金额:
$ 45.56万 - 项目类别:
Role and regulation of the splicing factor ASF/SF2 in human T lymphocyte physiolo
剪接因子ASF/SF2在人T淋巴细胞生理中的作用及调控
- 批准号:
8843361 - 财政年份:2012
- 资助金额:
$ 45.56万 - 项目类别:
Role and regulation of the splicing factor ASF/SF2 in human T lymphocyte physiolo
剪接因子ASF/SF2在人T淋巴细胞生理中的作用及调控
- 批准号:
8462912 - 财政年份:2012
- 资助金额:
$ 45.56万 - 项目类别:
相似海外基金
Alternative splicing of Grin1 controls NMDA receptor function in physiological and disease processes
Grin1 的选择性剪接控制生理和疾病过程中的 NMDA 受体功能
- 批准号:
488788 - 财政年份:2023
- 资助金额:
$ 45.56万 - 项目类别:
Operating Grants
RBFOX2 deregulation promotes pancreatic cancer progression through alternative splicing
RBFOX2 失调通过选择性剪接促进胰腺癌进展
- 批准号:
10638347 - 财政年份:2023
- 资助金额:
$ 45.56万 - 项目类别:
Long Noncoding RNA H19 Mediating Alternative Splicing in ALD Pathogenesis
长非编码 RNA H19 介导 ALD 发病机制中的选择性剪接
- 批准号:
10717440 - 财政年份:2023
- 资助金额:
$ 45.56万 - 项目类别:
Using proteogenomics to assess the functional impact of alternative splicing events in glioblastoma
使用蛋白质基因组学评估选择性剪接事件对胶质母细胞瘤的功能影响
- 批准号:
10577186 - 财政年份:2023
- 资助金额:
$ 45.56万 - 项目类别:
Alternative splicing regulation of CLTC in the heart
心脏中 CLTC 的选择性剪接调节
- 批准号:
10749474 - 财政年份:2023
- 资助金额:
$ 45.56万 - 项目类别:
Nitric oxide as a novel regulator of alternative splicing
一氧化氮作为选择性剪接的新型调节剂
- 批准号:
10673458 - 财政年份:2023
- 资助金额:
$ 45.56万 - 项目类别:
Alternative splicing as an evolutionary driver of phenotypic plasticity
选择性剪接作为表型可塑性的进化驱动力
- 批准号:
2884151 - 财政年份:2023
- 资助金额:
$ 45.56万 - 项目类别:
Studentship
Rescuing SYNGAP1 haploinsufficiency by redirecting alternative splicing
通过重定向选择性剪接挽救 SYNGAP1 单倍体不足
- 批准号:
10660668 - 财政年份:2023
- 资助金额:
$ 45.56万 - 项目类别:
CAREER: Mechanotransduction, transcription, and alternative splicing in cell biology
职业:细胞生物学中的机械转导、转录和选择性剪接
- 批准号:
2239056 - 财政年份:2023
- 资助金额:
$ 45.56万 - 项目类别:
Continuing Grant
Investigating the role of alternative splicing in the islets of Langerhans in developing diabetes.
研究朗格汉斯岛中选择性剪接在糖尿病发生中的作用。
- 批准号:
468851650 - 财政年份:2022
- 资助金额:
$ 45.56万 - 项目类别:
Research Grants